[go: up one dir, main page]

NO974486L - Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation - Google Patents

Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation

Info

Publication number
NO974486L
NO974486L NO974486A NO974486A NO974486L NO 974486 L NO974486 L NO 974486L NO 974486 A NO974486 A NO 974486A NO 974486 A NO974486 A NO 974486A NO 974486 L NO974486 L NO 974486L
Authority
NO
Norway
Prior art keywords
ridogrel
treatment
dose
formulations
low
Prior art date
Application number
NO974486A
Other languages
Norwegian (no)
Other versions
NO974486D0 (en
Inventor
Maria-Helena Joris J Verlinden
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO974486L publication Critical patent/NO974486L/en
Publication of NO974486D0 publication Critical patent/NO974486D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det er beskrevet anvendelse av "Ridogrel" ved frem- stilling av et medikament egnet for behandling av inflammatoriske tarmsykdommer hvor "Ridogrel" til- føres i en daglig dose fra 0,01 mg per kg kropps- vekt til 0,5 mg per kg kroppsvekt, samt farmaszy- tiske sammensetninger omfattende "Ridogrel".The use of "Ridogrel" has been described in the preparation of a medicament suitable for the treatment of inflammatory bowel diseases wherein "Ridogrel" is administered at a daily dose of 0.01 mg per kg body weight to 0.5 mg per kg body weight. , as well as pharmaceutical compositions comprising "Ridogrel".

NO974486A 1995-03-28 1997-09-29 Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation NO974486D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200768 1995-03-28
PCT/EP1996/001229 WO1996030016A2 (en) 1995-03-28 1996-03-18 Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases

Publications (2)

Publication Number Publication Date
NO974486L true NO974486L (en) 1997-09-29
NO974486D0 NO974486D0 (en) 1997-09-29

Family

ID=8220134

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974486A NO974486D0 (en) 1995-03-28 1997-09-29 Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation

Country Status (10)

Country Link
EP (1) EP0817631A2 (en)
JP (1) JPH10511097A (en)
AR (1) AR002727A1 (en)
AU (1) AU5397496A (en)
CA (1) CA2215160A1 (en)
HU (1) HUP9900309A3 (en)
IL (1) IL117670A (en)
NO (1) NO974486D0 (en)
WO (1) WO1996030016A2 (en)
ZA (1) ZA962461B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
WO2002072069A1 (en) * 2001-03-12 2002-09-19 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation
ITRM20050389A1 (en) 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
UA107562C2 (en) 2008-12-05 2015-01-26 METHOD OF TREATMENT OF PSORIASIS
PT2396081T (en) 2009-02-16 2017-07-11 Nogra Pharma Ltd Alkylamido compounds and uses thereof
EP2811993B1 (en) 2012-02-09 2019-10-09 Nogra Pharma Limited Methods of treating fibrosis
IN2014DN08157A (en) 2012-04-18 2015-05-01 Nogra Pharma Ltd
WO2017046343A1 (en) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same
SI3921299T1 (en) 2019-02-08 2025-03-31 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Also Published As

Publication number Publication date
CA2215160A1 (en) 1996-10-03
ZA962461B (en) 1997-09-29
WO1996030016A3 (en) 1997-01-30
JPH10511097A (en) 1998-10-27
AR002727A1 (en) 1998-04-29
IL117670A0 (en) 1996-07-23
HUP9900309A2 (en) 1999-05-28
IL117670A (en) 2000-02-29
HUP9900309A3 (en) 1999-11-29
AU5397496A (en) 1996-10-16
WO1996030016A2 (en) 1996-10-03
NO974486D0 (en) 1997-09-29
MX9707394A (en) 1997-11-29
EP0817631A2 (en) 1998-01-14

Similar Documents

Publication Publication Date Title
MY125662A (en) Pharmaceutical formulations containing darifenacin
BRPI0015284B8 (en) controlled release hydrocodone formulations
CA2227887A1 (en) Pharmaceutical compositions of conjugated estrogens and methods for their use
EP0254067A3 (en) Composition for metastasis prevention
KR970061244A (en) Pharmaceutical composition for treating dementia
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
HUP9801241A2 (en) Azathioprine compositions for colonic administration and process for their preparation
NO974486L (en) Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation
ATE254463T1 (en) USE OF VALACICLOVIR FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF GENITAL HERPES BY ONCE DAILY ADMINISTRATION
IL135235A0 (en) Method and composition for preventing nephrotoxicity caused by cyclosporins and tacrolimus
CA2180178A1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
JP2000512270A (en) Compositions and methods for the treatment of herpes simplex
EP0190851B1 (en) Improved antiinflammatory composition
WO1993017691A3 (en) Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease
ATE91890T1 (en) MANUFACTURE OF A DRUG AGAINST ARTHRITIS AND RHEUMATISM.
JPH03500656A (en) Acyl carnitine, a drug for the treatment and prevention of viral infections
AU640207B2 (en) Process and composition for the treating of injuries caused by the radiation of heat and light
RU99112967A (en) METHOD FOR TREATMENT AND PREVENTION OF PIG DYSENTERY
US4156003A (en) Treatment of hypertension with combination of clofibrinic acid or clofibrate with cinnarizine
IT8247658A1 (en) Medicines based on condensed imidazole derivatives for the treatment of urinary disorders
KR830008678A (en) Analgesic composition
WO1999029330A8 (en) Composition and method for treating nonalcoholic steatohepatitis
RU2121347C1 (en) Medicinal preparation
EP0230125A1 (en) Admixtures of diflunisal and tromethamine
TH25792A (en) Low-dose Ridogel formula